Skip to main content
logo
Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.7550
-0.0635 (-7.76%)
Mar 30, 2026, 12:21 PM EDT - Market open

Evogene Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.855.582.981.680.93
Revenue Growth (YoY)
-30.91%87.02%78.03%80.11%-10.58%
Cost of Revenue
4.092.381.490.910.77
Gross Profit
-0.243.21.490.770.16
Selling, General & Admin
5.768.987.5310.429.99
Research & Development
7.9912.5116.220.7921.13
Other Operating Expenses
0.040.51--3.5-
Total Operating Expenses
13.792223.7227.7131.12
Operating Income
-14.03-18.8-22.23-26.94-30.95
Interest Income
2.517.391.210.521.94
Interest Expense
-1.93-3.36-0.93-3.33-1.41
Other Non-Operating Income (Expense)
0.614.070.29-2.810.52
Total Non-Operating Income (Expense)
1.198.110.57-5.631.04
Pretax Income
-13.5-14.81-21.95-29.75-30.43
Provision for Income Taxes
00.010.020.090.01
Net Income
-8.49-16.49-23.88-26.64-27.79
Minority Interest in Earnings
0.66-1.57-2.08-3.21-2.65
Earnings From Discontinued Operations
5.67-3.24-3.99--
Net Income to Common
-8.49-16.49-23.88-26.64-27.79
Shares Outstanding (Basic)
86544
Shares Outstanding (Diluted)
86544
Shares Change (YoY)
38.21%24.14%10.80%2.44%43.59%
EPS (Basic)
-1.08-2.90-5.20-6.43-6.90
EPS (Diluted)
-1.08-2.90-5.20-6.43-6.90
Free Cash Flow
-13.64-20.33-22.15-24.85-25.56
Free Cash Flow Per Share
-1.73-3.57-4.83-6.00-6.32
Gross Margin
-6.25%57.32%50.03%45.73%17.53%
Operating Margin
-364.24%-337.17%-745.51%-1608.42%-3328.28%
Profit Margin
-553.49%-589.40%-1606.94%-1781.73%-3273.66%
FCF Margin
-353.93%-364.46%-742.92%-1483.52%-2748.71%
EBITDA
-12.89-17.42-20.93-24.36-28.72
EBITDA Margin
-334.54%-312.41%-701.91%-1454.39%-3088.06%
EBIT
-14.03-18.8-22.23-26.94-30.95
EBIT Margin
-364.24%-337.17%-745.51%-1608.42%-3328.28%
Effective Tax Rate
-0.01%-0.06%-0.09%-0.30%-0.04%
Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q